Diffusing Capacity of Carbon Monoxide in Assessment of Chronic Obstructive Pulmonary Disease.

[1]  N. Yu,et al.  Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD , 2017, International journal of chronic obstructive pulmonary disease.

[2]  E. Arias,et al.  Mortality in the United States, 2016. , 2017, NCHS data brief.

[3]  N. Roche,et al.  Defining the “Frequent Exacerbator” Phenotype in COPD: A Hypothesis‐Free Approach , 2017, Chest.

[4]  S. Stanojevic,et al.  Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians , 2017, European Respiratory Journal.

[5]  Bruce D. Johnson,et al.  Influence of resting lung diffusion on exercise capacity in patients with COPD , 2017, BMC Pulmonary Medicine.

[6]  J. Guenette,et al.  Resting Physiological Correlates of Reduced Exercise Capacity in Smokers with Mild Airway Obstruction , 2017, COPD.

[7]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.

[8]  Camilla Bianchi,et al.  Prediction models for exacerbations in patients with COPD , 2017, European Respiratory Review.

[9]  D. Mannino,et al.  Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD , 2016, International journal of chronic obstructive pulmonary disease.

[10]  T. Suda,et al.  Morphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary disease , 2016, International journal of chronic obstructive pulmonary disease.

[11]  S. H. Lee,et al.  Lower diffusing capacity with chronic bronchitis predicts higher risk of acute exacerbation in chronic obstructive lung disease. , 2016, Journal of thoracic disease.

[12]  M. Molina-Molina,et al.  Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease , 2016, PloS one.

[13]  Megha A. Parikh,et al.  Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study. , 2015, American journal of respiratory and critical care medicine.

[14]  H. Thompson,et al.  Prognosis in Chronic Obstructive Pulmonary Disease1, 2 , 2015 .

[15]  A. Liebow.  Pulmonary emphysema with special reference to vascular changes. , 2015, The American review of respiratory disease.

[16]  Joyce D. Schroeder,et al.  Relationships between diffusing capacity for carbon monoxide (DLCO), and quantitative computed tomography measurements and visual assessment for chronic obstructive pulmonary disease. , 2015, European journal of radiology.

[17]  Himanshu Gupta,et al.  Pulmonary Artery Enlargement Is Associated With Right Ventricular Dysfunction and Loss of Blood Volume in Small Pulmonary Vessels in Chronic Obstructive Pulmonary Disease , 2015, Circulation. Cardiovascular imaging.

[18]  E. Ford,et al.  Employment and Activity Limitations Among Adults with Chronic Obstructive Pulmonary Disease — United States, 2013 , 2015, MMWR. Morbidity and mortality weekly report.

[19]  S. Riedel,et al.  Pulmonales kapilläres Blutvolumen und Membrankomponente der pulmonalen Diffusionskapazität bei Patienten mit chronisch obstruktiver Bronchitis (COPD) , 2014, Pneumologie.

[20]  Raúl San José Estépar,et al.  Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. , 2013, American journal of respiratory and critical care medicine.

[21]  Miranda Kirby,et al.  On the role of abnormal DLCO in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI , 2013, Thorax.

[22]  C. Janson,et al.  Impaired Carbon Monoxide Diffusing Capacity is the Strongest Predictor of Exercise Intolerance in COPD , 2013, COPD.

[23]  Edwin K Silverman,et al.  GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. , 2013, The Lancet. Respiratory medicine.

[24]  M. Polkey,et al.  Lung function indices for predicting mortality in COPD , 2013, European Respiratory Journal.

[25]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[26]  S. Suissa,et al.  Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality , 2012, Thorax.

[27]  Nicola A Hanania,et al.  Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. , 2011, Radiology.

[28]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[29]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[30]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[31]  P. Jones.  Health Status and the Spiral of Decline , 2009, COPD.

[32]  R. Crapo,et al.  Standardization of the single-breath diffusing capacity in a multicenter clinical trial. , 2007, Chest.

[33]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[34]  V. Peinado,et al.  Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD , 2002, European Respiratory Journal.

[35]  L. Neas,et al.  Pulmonary function levels as predictors of mortality in a national sample of US adults. , 1998, American journal of epidemiology.

[36]  J. Best,et al.  Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. , 1991, The European respiratory journal.

[37]  N. Müller,et al.  Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. , 1990, The American review of respiratory disease.

[38]  J. Hogg,et al.  Pulmonary vascular structure and function in chronic obstructive pulmonary disease. , 1988, Thorax.

[39]  R. Kanner,et al.  Predictors of survival in subjects with chronic airflow limitation. , 1983, The American journal of medicine.

[40]  B. Burrows,et al.  Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. , 1979, The American review of respiratory disease.

[41]  J. Vance,et al.  Newer Aspects of the Pulmonary Vasculature in Chronic Lung Disease , 1968, Angiology.

[42]  ATS Statement , 2002 .

[43]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[44]  P De Vuyst,et al.  Comparison of computed density and microscopic morphometry in pulmonary emphysema. , 1996, American journal of respiratory and critical care medicine.

[45]  N J Morrison,et al.  Pulmonary capillary blood volume in emphysema. , 1990, The American review of respiratory disease.

[46]  H. Colebatch,et al.  Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. , 1990, The American review of respiratory disease.

[47]  H. Thompson,et al.  Prognosis in chronic obstructive pulmonary disease. , 1973, The American review of respiratory disease.

[48]  G. D. Scarrow.  The pulmonary angiogram in chronic bronchitis and emphysema. , 1966, Clinical radiology.